Determinant of the effectiveness of GLP-1 in type 2 diabetes

被引:0
|
作者
Toft-Nielsen, MB
Madsbad, S
Damholt, MB
Holst, JJ
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
516
引用
收藏
页码:A127 / A127
页数:1
相关论文
共 50 条
  • [1] Determinants of the effectiveness of GLP-1 in type 2 diabetes.
    Toft-Nielsen, MB
    Madsbad, S
    Damholt, MB
    Holst, JJ
    DIABETOLOGIA, 2000, 43 : A147 - A147
  • [2] Effectiveness of GLP-1 Analogues in Type 2 Diabetes mellitus
    Schuett, Morten
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (1-2) : 15 - 15
  • [3] GLP-1 for type 2 diabetes
    Ahren, Bo
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1239 - 1245
  • [4] In type 2 diabetes, the effectiveness and side effects of GLP-1 RAs vary
    O'Brien, Clare
    Dinneen, Sean F.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (05) : JC55 - JC55
  • [5] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [6] GLP-1 based therapy for type 2 diabetes
    Arulmozhi, DK
    Portha, B
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) : 96 - 108
  • [7] Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Almohareb, Sumaya N.
    Alfayez, Osamah M.
    Aljuaid, Shoroq S.
    Alshahrani, Walaa A.
    Bakhsh, Ghalia
    Alshammari, Mohammed K.
    Al Yami, Majed S.
    Alshaya, Omar A.
    Alomran, Abdullah S.
    Korayem, Ghazwa B.
    Almohammed, Omar A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [8] GLP-1 agonists in type 1 diabetes
    Pettus, Jeremy
    Hirsch, Irl
    Edelman, Steven
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 317 - 323
  • [9] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [10] Effectiveness and Tolerability Profile of GLP-1 Receptor Agonists in Elderly Patients with Type 2 Diabetes
    Gorgojo-Martinez, Juan J.
    Feo-Ortega, Gara
    Serrano-Moreno, Clara
    Sanz-Velasco, Alberto
    DIABETES, 2016, 65 : A573 - A573